Results 11 to 20 of about 8,951 (170)

Safety and efficacy of double-balloon catheter for cervical ripening: a Bayesian network meta-analysis of randomized controlled trials

open access: yesBMC Pregnancy and Childbirth, 2022
Background Various methods are used for cervical ripening during the induction of labor. Mechanical and pharmacological methods are commonly used for cervical ripening.
Ge Zhao, Guang Song, Jing Liu
doaj   +1 more source

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

open access: yesPLoS ONE, 2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) can produce adverse effects by inhibiting prostaglandin (PG) synthesis. A PGE1 analogue, misoprostol, is often utilized to alleviate NSAID-related gastrointestinal side effects. This study examined the effect
Dustin L Cooper   +11 more
doaj   +1 more source

Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis

open access: yesScientific Reports, 2017
The efficacy and safety of misoprostol alone for missed abortion varied with different regimens. To evaluate existing evidence for the medical management of missed abortion using misoprostol, we undertook a comprehensive review and meta-analysis.
Hang-lin Wu   +4 more
doaj   +1 more source

A comparative study between isosorbide mononitrate (IMN) versus misoprostol prior to hysteroscopy

open access: yesMiddle East Fertility Society Journal, 2010
Objective: To compare the efficacy of a nitric oxide donor (isosorbide mononitrate) and a prostaglandin E1 analogue (misoprostol) for cervical priming before hysteroscopy. Design: Comparative clinical trial.
Waleed El-Khayat   +2 more
doaj   +1 more source

Intravaginal misoprostol versus sublingual misoprostol for second trimester pregnancy termination: a randomized controlled trial

open access: yesClinical and Experimental Obstetrics & Gynecology, 2021
Objective: To compare the efficacy and adverse effects of 400 mcg misoprostol for second trimester pregnancy termination via the intravaginal or sublingual route.
Saipin Pongsatha, Theera Tongsong
doaj   +1 more source

Misoprostol Induced Convulsion- A Rare Side Effect of Misoprostol

open access: yesJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2017
Misoprostol, a synthetic prostaglandin E1 has wider application in obstetrics gynaecology. It has been recommended in the prophylaxis and treatment of Post Partum Haemorrhage (PPH) by Federation of Obstetrics and Gynaecology (FIGO), World Health Organisation (WHO) and American College of Obstetrics and Gynaecology (ACOG).
Nalini Sharma   +3 more
openaire   +3 more sources

Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report

open access: yesNovelty in Biomedicine, 2022
Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj   +1 more source

Effect of mifepristone-misoprostol versus misoprostol in the management of intrauterine fetal death: A comparative study

open access: yesArchives of Medicine and Health Sciences, 2020
Background and Aim: The most undesirable consequence of pregnancy is intrauterine fetal death (IUFD) which causes a lot of emotional and medical distress for which medical induction of labor, by routinely used prostaglandins, is recommended.
T R Sindhuri   +3 more
doaj   +1 more source

Oral misoprostol with mifepristone versus misoprostol alone for inducing labor in intrauterine fetal death: A randomized placebo-controlled trial

open access: yesInternational Journal of Advanced Medical and Health Research, 2017
Context: Intrauterine fetal death (IUFD) causes emotional distress and could result in intrauterine infection. In view of these complications, medical induction is recommended, if it is safe.
Yazhini Arjunan   +4 more
doaj   +1 more source

The safety of misoprostol

open access: yesInternational Journal of Gynecology & Obstetrics, 2006
TITLE: The Safety of Misoprostol AUTHOR: Anke Hemmerling, MD, MPH Bixby Fellow of Population and International Health University of California, Berkeley School of Public Health 513 Warren Hall Berkeley, CA 94720-6390 Email: anke@berkeley.edu Misoprostol, Safety, Post Partum Hemorrhage KEYWORDS: Misoprostol is currently on the WHO Essential Drug List ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy